Nunnery and Abramson discussed the transformative effects of next-generation oral SERDs in hormone receptor–positive breast cancer management.
Vandana G. Abramson, MD
Advertisement
Vandana G. Abramson, MD, of Vanderbilt-Ingram Cancer Center
Articles by Vandana G. Abramson, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on OncLive
1
In Vivo CD19/CD20 CAR T-Cell Therapy Is Safe, Yields 100% ORR at Phase 1, Dose Level 2 in R/R Non-Hodgkin Lymphomas
2
Tacabrutideg Is Tolerable and Shows Efficacy Signals Across BTK Inhibitor–Naive CLL and Other B-Cell Malignancies
3
Subcutaneous Blinatumomab Yields High Efficacy Rates in R/R Ph+ B-ALL
4
Real-World Analysis Reveals Liso-Cel Elicits High Response Rates in R/R Mantle Cell Lymphoma
5